Prognostic factors in brain metastases: Can we determine patients who do not benefit from whole-brain radiotherapy?

Clinical Oncology

Volumn 16, Issue 5, 2004, Pages 332-338

  Lock, M ^a   Chow, E ^b   Pond, G R ^c   Do, V ^d   Danjoux, C ^b   Dinniwell, R ^e   Lea, J ^e   Bezjak, Andrea ^e  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d WESTMEAD HOSPITAL   (Australia)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

Brain metastases; Prognostic factors; Radiotherapy

Indexed keywords

CORTICOSTEROID;

ADULT; AGE; AGED; ARTICLE; BRAIN METASTASIS; BRAIN RADIATION; CANCER CENTER; CANCER CONTROL; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; DEATH; FEMALE; FOLLOW UP; GENDER; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATIENT REFERRAL; PERFORMANCE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RADIATION DOSE FRACTIONATION; STEROID THERAPY; WEIGHT REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHOTONS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RADIOTHERAPY, CONFORMAL; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 3242795108     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2004.03.006     Document Type: Article

References (32)

1. Johnson J.D. Young B. Demographics of brain metastases Neurosurg Clin North Am 7 1996 337-344
2. Paterson A.H. Agarwal M. Lees A. et al. Brain metastases in breast cancer patients receiving adjuvant chemotherapy Cancer 49 1982 651-654
3. Pieterman R.M. Que T.H. Elsinga P.H. Comparison of (11) C-choline and (18) F-FDG PET in primary diagnosis and staging of patients with thoracic cancer J Nucl Med 43 2002 167-172
4. Coia L.R. Aaronson N. Linggood R. et al. A report of the consensus workshop panel on the treatment of brain metastases Int J Radiat Oncol Biol Phys 23 1992 223-227
5. Paszat L. Shenouda G. Blood P. et al. The role of palliative radiotherapy for brain metastases Can J Oncol 6 suppl 1 1996 48-53
6. Osoba D. Aaronson N.K. Muller M. et al. The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires Qual Life Res 5 1996 139-150
7. Weitzner M.A. Meyers C.A. Gelke C.K. et al. The functional assessment of cancer therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumours Cancer 75 1995 1151-1161
8. Sneeuw K.C. Aaronson K. Sprangers M.A. et al. Evaluating the quality of life of cancer patients: assessments by patients, significant others, physicians and nurses Br J Cancer 81 1999 87-94
9. Miller A.B. Hoogstraten B. Staquet M. et al. Reporting results of cancer treatment Cancer 47 1981 207-214
10. Order S.E. Hellman S. von Essen C.F. et al. Improvement in quality of survival following whole-brain irradiation for brain metastases Radiology 91 1968 149-153
11. Van der Steen-Banasik E. Hermans J. Tjho-Heslinga R. et al. The objective response of brain metastases on radiotherapy: a prospective study using computer tomography Acta Oncol 31 1992 777-780
12. Epstein B.E. Scott C.B. Sause W.T. et al. Improved survival duration in patients with unresected solitary brain metastasis using accelerated hyperfractionated radiation therapy at total doses of 54.4 Gray and greater Cancer 71 1993 1362-1367
13. Bezjak A. Adam J. Panzarella T. et al. Radiotherapy for brain metastases: defining response Radiother Oncol 61 2001 71-76
14. Horton J. Baxter D.H. Olson K.B. et al. The management of metastases to the brain by irradiation and corticosteroids Am J Roentgenol Radium Ther Nucl Med 3 1971 334-336
15. Gaspar L. Scott C. Rotman M. et al. Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials Int J Radiat Oncol Biol Phys 37 1997 745-751
16. Priestman T.J. Dunn J. Brada M. et al. Final results of the Royal College of Radiologists' trial comparing two different radiotherapy schedules in the treatment of cerebral metastases Clin Oncol 8 1996 308-315
17. Bezjak A. Adam J. Barton R. et al. Symptom response after palliative radiotherapy for patients with brain metastases Eur J Cancer 38 2002 487-496
18. Lagerwaard F.J. Levendag P.C. Nowak P.J. et al. Identification of prognostic factors in patients with brain metastases: a review of 1292 patients Int J Radiat Oncol Biol Phys 43 1999 795-803
19. Kurtz J.M. Gelber R. Brady L.W. et al. Palliation of brain metastases in a favorable patient population: a randomized clinical trial by the Radiation Therapy Oncology Group Int J Radiat Oncol Biol Phys 7 1981 891-895
20. Diener-West M. Dobbins T.W. Walsh J.W. et al. Identification of an optimal subgroup for treatment evaluation of patients with brain metastases using RTOG study 7916 Int J Radiat Oncol Biol Phys 16 1989 669-673
21. Scott C.B. Scarantino C. Urtasun R. et al. Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06 Int J Radiat Oncol Biol Phys 40 1998 51-55
22. Gaspar L.E. Scott C. Murray K. et al. Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases Int J Radiat Oncol Biol Phys 47 2000 1001-1006
23. Lutterbach J. Bartelt S. Stancu E. et al. Patients with brain metastases: hope for recursive partitioning analysis (RPA) class 3 Radiother Oncol 63 2002 339-345
24. Posner J.B. Management of brain metastases Rev Neurol 148 1992 477-487
25. Altman D.G. Systematic reviews of evaluations of prognostic variables BMJ 28 323 2001 224-228
26. Simon R. Altman D.G. Statistical aspects of prognostic factor studies in oncology Br J Cancer 69 1994 979-985
27. Shaw E. Scott C. Souhami L. et al. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05 Int J Radiat Oncol Biol Phys 47 2000 291-298
28. Su M.Y. Yu H. Chiou J.Y. et al. Measurement of volumetric and vascular changes with dynamic contrast enhanced MRI for cancer therapy monitoring Technol Cancer Res Treat 1 2002 479-488
29. Lassman A.B. DeAngelis L.M. Brain metastases Neurol Clin 21 2003 1-23
30. Weber W.A. Avril N. Schwaiger M. Relevance of positron emission tomography (PET) in oncology Strahlenther Onkol 175 1999 356-373
31. Smalley S. Schray M.F. Laws E.R. et al. Adjuvant radiation therapy after surgical resection of solitary brain metastasis: association with pattern of failure and survival Int J Radiat Oncol Biol Phys 13 1987 1611-1616
32. Sawaya R. Considerations in the diagnosis of brain metastases Oncology 15 2001 1144-1154